Northern Europe says Skol To Biotechnology

Courtesy of BioCon Valley In the Middle Ages, the Hanseatic League, a free-trade alliance between cities situated along the shores of the Baltic Sea, built a major commercial center that enriched the participants. Today, the region's life sciences leaders have formed the ScanBalt organization with the same aims. Officially launched in 2002, ScanBalt encompasses the EU member states Denmark, Sweden, Finland, and Germany; the EU candidate countries Estonia, Latvia, Lithuania, and Poland; and No

Written byMartina Habeck
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

In the Middle Ages, the Hanseatic League, a free-trade alliance between cities situated along the shores of the Baltic Sea, built a major commercial center that enriched the participants. Today, the region's life sciences leaders have formed the ScanBalt organization with the same aims. Officially launched in 2002, ScanBalt encompasses the EU member states Denmark, Sweden, Finland, and Germany; the EU candidate countries Estonia, Latvia, Lithuania, and Poland; and Norway, Iceland, and Northwest Russia.

The countries to the west of the Baltic Sea are home to some of the most successful biotech clusters in Europe, with sophisticated laboratory facilities and an extensive community of biotech companies. The countries to the east offer a cheap infrastructure, a highly educated workforce, and a relatively positive public attitude towards biotechnology. Sixty-three universities and more than 700 biotech-related companies are based in the Baltic Sea region.

ScanBalt also incorporates two well-known Northern European biotechnology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies